Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
ORAGENICS INC (OGEN)
Sector: Healthcare; Industry: Biotechnology

Oragenics, Inc. develops novel antibiotics against infectious diseases and treatments for oral mucositis. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-06-17 Telling Fred Director Buy 10,084 $0.29 $2,884 No
2022-05-24 Telling Fred Director Buy 82,173 $0.29 $23,780 No
2022-05-20 Telling Fred Director Buy 65,718 $0.28 $18,638 No
2022-05-19 Telling Fred Director Buy 72,109 $0.28 $19,940 No
2020-11-24 Telling Fred Director Buy 100,000 $0.37 $37,000 No
2016-06-30 Telling Fred Director Buy 969,180 $0.52 $500,000 No
2014-11-14 Telling Fred Director Buy 27,000 $0.95 $25,541 No
2012-07-31 Telling Fred Director Buy 98,111 $1.50 $147,166 No
2011-08-25 Telling Fred Director Buy 6,460 $2.39 $15,439 No
2011-08-23 Telling Fred Director Buy 3,540 $2.26 $8,017 No

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

Upwork Inc (UPWK) - GRETSCH GREGORY C. Director of Upwork, made a bulk buy of 500K shares right before the big gap up, which is also the largest buy of the past 12 months.